Archive · 24 Jul 2026
Lord’s Mark Industries Issues Shares at ₹158
Lord’s Mark Industries is issuing 10,28,483 equity shares at ₹158 each.
This is part of an agreement with Bennett, Coleman and Co., who wanted to convert their share entitlement into equity.
The company believes this shows confidence in their future plans and growth.
Lord’s Mark Industries works in healthcare, diagnostics, MedTech, dialysis, renewable energy, and advanced medical technologies.
Their shares are currently trading at ₹94, which is lower than the issue price.
The Managing Director, Sachidanand Upadhyay, says this reflects the trust institutions have in the company.
Lord’s Mark Industries is issuing 10,28,483 equity shares at ₹158 per share.
The issuance is part of a Share-Cum-Warrant subscription agreement with Bennett, Coleman and Co.
The issue price reflects confidence in the company's long-term strategy and growth potential.
Lord’s Mark Industries operates in healthcare, diagnostics, MedTech, dialysis, renewable energy, and advanced medical technologies.
The company's shares are currently trading at ₹94, which is lower than the issue price.
- Who
- Lord’s Mark Industries and Bennett, Coleman and Co.
- What
- Issuance of 10,28,483 equity shares at ₹158 per share
- When
- July 24, 2026
- Where
- India
- Why
- To convert share entitlement into equity and reflect confidence in the company's long-term strategy and growth potential
Investor Confidence
Market Performance
Investor Confidence
Investor Confidence
The issuance of shares at ₹158 reflects strong confidence in Lord’s Mark Industries' long-term strategy and growth potential.
Market Performance
Despite the confidence shown by Bennett, Coleman and Co., the market performance of Lord’s Mark Industries shares remains relatively low at ₹94.
- Company
- Lord’s Mark Industries
- Shares Issued
- 10,28,483
- Issue Price
- ₹158 per share
- Market Price
- ₹94 per share
- Investor
- Bennett, Coleman and Co.
- Managing Director
- Sachidanand Upadhyay
- Date
- July 24, 2026